How to buy Assertio stock

Assertio Holdings, Inc is a drug manufacturers-specialty & generic business based in the US. Assertio shares (ASRT) are listed on the NASDAQ and all prices are listed in US Dollars. Assertio employs 27 staff and has a trailing 12-month revenue of around 0.00.

Assertio share price

Use our graph to track the performance of ASRT stocks over time.

Assertio shares at a glance

• Key figures

Information last updated 2021-04-15.

52-week range	$0.33 - $1.45
50-day moving average	$0.81
200-day moving average	$0.66
Wall St. target price	$1.55
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.06

Buy Assertio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Assertio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Assertio Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Assertio under- or over-valued?

Valuing Assertio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Assertio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Assertio's EBITDA

Assertio's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million.

The EBITDA is a measure of a Assertio's overall financial performance and is widely used to measure a its profitability.

Assertio financials

Revenue TTM	$108.1 million
Gross profit TTM	$92.3 million
Return on assets TTM	-6.43%
Return on equity TTM	-49.61%
Profit margin	-26.03%
Book value	$0.49
Market capitalisation	$96 million

TTM: trailing 12 months

Shorting Assertio shares

There are currently 3.8 million Assertio shares held short by investors – that's known as Assertio's "short interest". This figure is 13.2% down from 4.4 million last month.

There are a few different ways that this level of interest in shorting Assertio shares can be evaluated.

Assertio's "short interest ratio" (SIR)

Assertio's "short interest ratio" (SIR) is the quantity of Assertio shares currently shorted divided by the average quantity of Assertio shares traded daily (recently around 10.8 million). Assertio's SIR currently stands at 0.35. In other words for every 100,000 Assertio shares traded daily on the market, roughly 350 shares are currently held short.

However Assertio's short interest can also be evaluated against the total number of Assertio shares, or, against the total number of tradable Assertio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Assertio's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Assertio shares in existence, roughly 20 shares are currently held short) or 0.022% of the tradable shares (for every 100,000 tradable Assertio shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Assertio.

Find out more about how you can short Assertio stock.

Assertio share dividends

We're not expecting Assertio to pay a dividend over the next 12 months.

Assertio share price volatility

Over the last 12 months, Assertio's shares have ranged in value from as little as $0.33 up to $1.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assertio's is 1.5758. This would suggest that Assertio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Assertio overview

Assertio Holdings, Inc. , a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020.

Frequently asked questions

• What percentage of Assertio is owned by insiders or institutions?

  Currently 2.497% of Assertio shares are held by insiders and 22.226% by institutions.

• How many people work for Assertio?

  Latest data suggests 27 work at Assertio.

• When does the fiscal year end for Assertio?

  Assertio's fiscal year ends in December.

• Where is Assertio based?

  Assertio's address is: 100 South Saunders Road, Lake Forest, IL, United States, 60045

• What is Assertio's ISIN number?

  Assertio's international securities identification number is: US04546C1062

• What is Assertio's CUSIP number?

  Assertio's Committee on Uniform Securities Identification Procedures number is: 04545L107